001     178220
005     20240229133802.0
024 7 _ |a 10.3389/fonc.2021.771312
|2 doi
024 7 _ |a pmid:34926279
|2 pmid
024 7 _ |a pmc:PMC8678088
|2 pmc
024 7 _ |a altmetric:118017328
|2 altmetric
037 _ _ |a DKFZ-2021-03217
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lu, Ye
|0 P:(DE-He78)ebb819874e9553d89bd480e6811dc0f3
|b 0
|e First author
|u dkfz
245 _ _ |a Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk.
260 _ _ |a Lausanne
|c 2021
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1640254519_5553
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C055#LA:C055#
520 _ _ |a Although 21 pancreatic cancer susceptibility loci have been identified in individuals of European ancestry through genome-wide association studies (GWASs), much of the heritability of pancreatic cancer risk remains unidentified. A recessive genetic model could be a powerful tool for identifying additional risk variants. To discover recessively inherited pancreatic cancer risk loci, we performed a re-analysis of the largest pancreatic cancer GWAS, the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4), including 8,769 cases and 7,055 controls of European ancestry. Six single nucleotide polymorphisms (SNPs) showed associations with pancreatic cancer risk according to a recessive model of inheritance. We replicated these variants in 3,212 cases and 3,470 controls collected from the PANcreatic Disease ReseArch (PANDoRA) consortium. The results of the meta-analyses confirmed that rs4626538 (7q32.2), rs7008921 (8p23.2) and rs147904962 (17q21.31) showed specific recessive effects (p<10-5) compared with the additive effects (p>10-3), although none of the six SNPs reached the conventional threshold for genome-wide significance (p < 5×10-8). Additional bioinformatic analysis explored the functional annotations of the SNPs and indicated a possible relationship between rs36018702 and expression of the BCL2L11 and BUB1 genes, which are known to be involved in pancreatic biology. Our findings, while not conclusive, indicate the importance of considering non-additive genetic models when performing GWAS analysis. The SNPs associated with pancreatic cancer in this study could be used for further meta-analysis for recessive association of SNPs and pancreatic cancer risk and might be a useful addiction to improve the performance of polygenic risk scores.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a genetic polymorphisms
|2 Other
650 _ 7 |a genome-wide association study
|2 Other
650 _ 7 |a pancreatic cancer
|2 Other
650 _ 7 |a recessive model
|2 Other
650 _ 7 |a susceptibility
|2 Other
700 1 _ |a Gentiluomo, Manuel
|b 1
700 1 _ |a Macauda, Angelica
|0 P:(DE-He78)b791a47b92809f7c54501331f72e0243
|b 2
|u dkfz
700 1 _ |a Gioffreda, Domenica
|b 3
700 1 _ |a Gazouli, Maria
|b 4
700 1 _ |a Petrone, Maria C
|b 5
700 1 _ |a Kelemen, Dezső
|b 6
700 1 _ |a Ginocchi, Laura
|b 7
700 1 _ |a Morelli, Luca
|b 8
700 1 _ |a Papiris, Konstantinos
|b 9
700 1 _ |a Greenhalf, William
|b 10
700 1 _ |a Izbicki, Jakob R
|b 11
700 1 _ |a Kiudelis, Vytautas
|b 12
700 1 _ |a Mohelníková-Duchoňová, Beatrice
|b 13
700 1 _ |a Bueno-de-Mesquita, Bas
|b 14
700 1 _ |a Vodicka, Pavel
|b 15
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 16
|u dkfz
700 1 _ |a Diener, Markus K
|b 17
700 1 _ |a Pezzilli, Raffaele
|b 18
700 1 _ |a Ivanauskas, Audrius
|b 19
700 1 _ |a Salvia, Roberto
|b 20
700 1 _ |a Szentesi, Andrea
|b 21
700 1 _ |a Aoki, Mateus Nóbrega
|b 22
700 1 _ |a Németh, Balázs C
|b 23
700 1 _ |a Sperti, Cosimo
|b 24
700 1 _ |a Jamroziak, Krzysztof
|b 25
700 1 _ |a Chammas, Roger
|b 26
700 1 _ |a Oliverius, Martin
|b 27
700 1 _ |a Archibugi, Livia
|b 28
700 1 _ |a Ermini, Stefano
|b 29
700 1 _ |a Novák, János
|b 30
700 1 _ |a Kupcinskas, Juozas
|b 31
700 1 _ |a Strouhal, Ondřej
|b 32
700 1 _ |a Souček, Pavel
|b 33
700 1 _ |a Cavestro, Giulia M
|b 34
700 1 _ |a Milanetto, Anna C
|b 35
700 1 _ |a Vanella, Giuseppe
|b 36
700 1 _ |a Neoptolemos, John P
|b 37
700 1 _ |a Theodoropoulos, George E
|b 38
700 1 _ |a van Laarhoven, Hanneke W M
|b 39
700 1 _ |a Mambrini, Andrea
|b 40
700 1 _ |a Moz, Stefania
|b 41
700 1 _ |a Kala, Zdenek
|b 42
700 1 _ |a Loveček, Martin
|b 43
700 1 _ |a Basso, Daniela
|b 44
700 1 _ |a Uzunoglu, Faik G
|b 45
700 1 _ |a Hackert, Thilo
|b 46
700 1 _ |a Testoni, Sabrina G G
|b 47
700 1 _ |a Hlaváč, Viktor
|b 48
700 1 _ |a Andriulli, Angelo
|b 49
700 1 _ |a Lucchesi, Maurizio
|b 50
700 1 _ |a Tavano, Francesca
|b 51
700 1 _ |a Carrara, Silvia
|b 52
700 1 _ |a Hegyi, Péter
|b 53
700 1 _ |a Arcidiacono, Paolo G
|b 54
700 1 _ |a Busch, Olivier R
|b 55
700 1 _ |a Lawlor, Rita T
|b 56
700 1 _ |a Puzzono, Marta
|b 57
700 1 _ |a Boggi, Ugo
|b 58
700 1 _ |a Guo, Feng
|0 P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919
|b 59
|u dkfz
700 1 _ |a Małecka-Panas, Ewa
|b 60
700 1 _ |a Capurso, Gabriele
|b 61
700 1 _ |a Landi, Stefano
|b 62
700 1 _ |a Talar-Wojnarowska, Renata
|b 63
700 1 _ |a Strobel, Oliver
|b 64
700 1 _ |a Gao, Xin
|0 P:(DE-He78)8218df9f6f41792399cd3a29b587e4e7
|b 65
|u dkfz
700 1 _ |a Vashist, Yogesh
|b 66
700 1 _ |a Campa, Daniele
|b 67
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 68
|e Last author
|u dkfz
773 _ _ |a 10.3389/fonc.2021.771312
|g Vol. 11, p. 771312
|0 PERI:(DE-600)2649216-7
|p 771312
|t Frontiers in oncology
|v 11
|y 2021
|x 2234-943X
909 C O |o oai:inrepo02.dkfz.de:178220
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)ebb819874e9553d89bd480e6811dc0f3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)b791a47b92809f7c54501331f72e0243
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 59
|6 P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 65
|6 P:(DE-He78)8218df9f6f41792399cd3a29b587e4e7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 68
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT ONCOL : 2019
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-01-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-01-27
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-01-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-01-27
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-01-27
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-01-27
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-01-27
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21